BIOMERICA, INC.
Income Statement
| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $876.0K | $987.0K | $1.2M | $1.4M | $749.0K | $1.1M | $1.6M | $1.8M |
| Cost of Revenue | $945.0K | $1.0M | $1.2M | $956.0K | $996.0K | $1.1M | $1.2M | $1.5M |
| Gross Profit | $-69.0K | $-44.0K | $51.0K | $424.0K | $-247.0K | $19.0K | $437.0K | $289.0K |
| Gross Margin | -7.9% | -4.5% | 4.2% | 30.7% | -33.0% | 1.7% | 26.7% | 16.0% |
| Operating Expenses | ||||||||
| Research & Development | $205.0K | $178.0K | $193.0K | $212.0K | $252.0K | $217.0K | $257.0K | $297.0K |
| SG&A Expense | $1.3M | $1.1M | $1.2M | $1.3M | $1.1M | $1.0M | $1.2M | $1.4M |
| Operating Income | $-1.5M | $-1.3M | $-1.4M | $-1.1M | $-1.6M | $-1.2M | $-993.0K | $-1.4M |
| Operating Margin | -174.8% | -131.5% | -113.5% | -81.0% | -209.1% | -108.1% | -60.7% | -75.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.1M | $-1.3M | $-1.3M | $5.0K | $-1.5M | $-1.2M | $-953.0K | $-1.3M |
| Income Tax Expense | $7.0K | $8.0K | $5.0K | $3.0K | $4.0K | $-4.0K | $-3.0K | $4.0K |
| Net Income | $-1.1M | $-1.3M | $-1.3M | $2.0K | $-1.5M | $-1.2M | $-950.0K | $-1.3M |
| Net Margin | -130.7% | -132.9% | -109.1% | 0.1% | -206.1% | -103.9% | -58.1% | -72.8% |
| EPS (Basic) | $-0.41 | $-0.44 | $-0.45 | $0.00 | $-0.99 | $-0.48 | $-0.06 | $-0.63 |
| EPS (Diluted) | $-0.41 | $-0.44 | $-0.45 | $0.00 | $-0.99 | $-0.48 | $-0.06 | $-0.63 |
| Shares Outstanding (Basic) | 2.9M | 3.0M | 2.9M | 2.6M | 2.3M | 2.4M | 2.1M | 2.1M |
| Shares Outstanding (Diluted) | 2.9M | 3.0M | 2.9M | 2.6M | 2.3M | 2.4M | 2.1M | 2.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |